Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Benevich Eric received 6,275 Neurocrine Biosciences, Inc. shares as an award (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Benevich Eric (Chief Commercial Officer) received 6,275 Neurocrine Biosciences, Inc. shares as an award, leaving 67,297 shares. Filed Sep 15, 2026 (Form 4).
- Awarded
- 6,275 shares
- Holding after
- 67,297 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 6,275 | 70,683 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 3,386 | US$156.22 | 67,297 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Benevich Eric
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Benevich Eric · Sep 10, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026